Sensitive and rapid HPLC quantification of tenofovir from hyaluronic acid-based nanomedicine |
| |
Authors: | Agrahari Vivek Youan Bi-Botti C |
| |
Institution: | (1) Laboratory of Future Nanomedicines and Theoretical Chronopharmaceutics, Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte, Kansas City, Missouri 64108, USA; |
| |
Abstract: | The purpose of this study was to develop and validate a rapid, sensitive, and specific reversed-phase high-performance liquid
chromatography method for the quantitative determination of native tenofovir (TNF) for various applications. Different analytical
performance parameters such as linearity, precision, accuracy, limit of quantification (LOQ), limit of detection (LOD), and
robustness were determined according to International Conference on Harmonization (ICH) guidelines. A Bridge™ C18 column (150 × 4.6 mm,
5 μm) was used as stationary phase. The retention time of TNF was 1.54 ± 0.03 min (n = 6). The assay was linear over the concentration range of 0.1–10 μg/mL. The proposed method was sensitive with LOD and LOQ
values equal to 50 and 100 ng/mL, respectively. The method was accurate with percent mean recovery from 95.41% to 102.90%
and precise as percent RSD (relative standard deviation) values for intra-day, and inter-day precision were less than 2%.
This method was utilized for the estimation of molar absorptivity of TNF at 259 nm (ε
259 = 12,518 L/mol/cm), calculated from linear regression analysis. The method was applied for determination of percentage of
encapsulation efficiency ( 22.93 ± 0.04%), drug loading (12.25 ± 1.03%), in vitro drug release profile in the presence of enzyme (43% release in the first 3 h) and purification analysis of hyaluronic acid-based
nanomedicine. |
| |
Keywords: | |
本文献已被 PubMed SpringerLink 等数据库收录! |
|